A novel aqueous suspoemulsion
A suspoemulsion, water-based technology, applied in the field of water-based suspoemulsion products, can solve the problems of not easy to obtain, complicated production process, high cost, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0100] The suspoemulsion formulation was prepared as follows:
[0101] a) Preparation of lambda-cyhalothrin phase emulsifiable concentrate:
[0102] The active ingredient lambda-cyhalothrin (Jiangsu Youshi Chemistry) and methyl oleate (Clariant) were mixed at room temperature. Let it stand for 30 minutes, add the emulsifier EL360 (Clariant), and stir until a uniform solution is formed.
[0103] Component
Composition (g)
Remarks
Lambda-cyhalothrin technical (Jiangsu Youshi)
5 (calculated as pure product)
[0104] Methyl oleate (Clariant)
5
EL360(Clariant)
3
Emulsifier
[0105] b) Preparation of dispersed particles of lufenuron (Shanghai Stone) active ingredient in continuous water phase:
[0106] Component
Composition (g)
Remarks
Lufenuron technical (Shanghai Stone)
5 (calculated as pure product)
Soprophor BSU (Rhodia)
0.5
Dispersant
Soprophor FLK(Rhodia)
1.5
Dispersant
Propylene glycol (DOW)
4
Antifre...
Embodiment 2
[0111] The suspoemulsion formulation was prepared as follows:
[0112] a) Preparation of Lambda-cyhalothrin EW phase oil-in-water emulsion:
[0113] Component
Composition (g)
Remarks
Lambda-cyhalothrin technical
8 (calculated as pure product)
Propylene Carbonate (Local)
8
Atlox4912(Croda)
2
Emulsifier
Tween 80 (Croda)
0.3
Emulsifier
[0114] The active ingredient Lambda-cyhalothrin is mixed with Solvesso 100 at room temperature. Let it stand for 30 minutes, add the emulsifier EL360 and stir until a homogeneous solution is formed. Then, the lambda-cyhalothrin EC phase is added to water with high shear to obtain the lambda-cyhalothrin EW phase.
[0115] b) Preparation of lufenuron dispersed particles in continuous water phase:
[0116]
[0117] The preparation of the concentrated suspension of lufenuron was carried out by the same general method as that contained in b) of Example 1.
[0118] c) Supoemulsion
[0119] The oil-in-water phase (a)...
Embodiment 3
[0121] The suspoemulsion formulation was prepared as follows:
[0122] a) Preparation of lambda-cyhalothrin phase emulsifiable concentrate:
[0123]
[0124] Lambda-cyhalothrin emulsifiable concentrates were prepared in the same general manner as in Example 1 a).
[0125] b) Preparation of lufenuron dispersed particles in the continuous water phase
[0126]
[0127] The preparation of the concentrated suspension of lufenuron was carried out by the same general method as that contained in b) of Example 1.
[0128] c) Supoemulsion
[0129] The suspoemulsion was prepared using the same general procedure as set out in c) of Example 1. The low-temperature storage stability (-5°C), high-temperature storage stability (54°C) and stability of the suspension agent when diluted at 30°C were tested.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
